Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.92 USD | -2.59% | -15.22% | -51.89% |
15/05 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/03 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.89% | 53Cr | |
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.34TCr | |
-0.29% | 2.18TCr | |
-9.28% | 1.81TCr | |
-41.70% | 1.67TCr | |
-15.33% | 1.6TCr | |
+5.80% | 1.4TCr | |
+28.03% | 1.17TCr |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Chardan Research Adjusts Price Target on Cabaletta Bio to $13 From $17, Reiterates Buy Rating